Pilot Payer-Provider Collaborations

Linda D. Bosserman, MD, FACP

Video Categories: Payer-Provider

Linda Bosserman provides insight into positive data around payer-provider collaborations
January 20, 2016

Making the Case for Combination Therapies

Dr Wainberg and Dr Gerson review why providers are using combination therapies and the eventual goal of investigators to hit specific targeted cells.

October 1, 2018

How International Standards for Molecular Biomarker Testing in Lung Cancer Have Influenced Which Tests are Routinely Performed

Drs. Roy Herbst and David Rimm discuss the 50-gene panel that has become an ISLC-mandated standard for all patients with lung cancer; however, the components of cancer biomarker testing panels must be fluid and respond to new developments in the field as reported in the literature and/or at international cancer [ Read More ]